सभी अध्ययन
सक्रिय लेकिन भर्ती नहींचरण3हस्तक्षेपात्मक

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

This research study, called ATTAIN-Hypertension, is investigating a new medication, orforglipron, for adults who have high blood pressure and are also overweight or living with obesity. The main goal is to find out if orforglipron is effective in lowering blood pressure and to check how safe it is for people to use. Participants will be randomly assigned to either receive the new medicine or a 'dummy' pill (placebo) that looks the same but contains no active drug. This is a common way to test new treatments, helping researchers understand the medicine's true effects. It's part of a larger research programme looking into orforglipron.

एक नजर में

स्थिति
सक्रिय लेकिन भर्ती नहीं
चरण
चरण3
प्रायोजक
एली लिली एंड कंपनी
नामांकन लक्ष्य
487
प्रारंभ
30 अप्रैल 2025
अनुमानित पूर्णता
01 सितम्बर 2027

यह अध्ययन किस बारे में है?

This study, known as ATTAIN-Hypertension, is a clinical trial focused on a new medicine called orforglipron (which has a code name LY3502970). The main purpose of this research is to see if orforglipron can help people who have high blood pressure, especially if they are also overweight or living with obesity. High blood pressure can lead to serious health problems like heart attacks and strokes, so finding effective treatments is very important.

Researchers want to understand two key things: first, if orforglipron actually works to lower blood pressure in this group of people (this is called its 'efficacy'), and second, whether it is safe to use and what side effects it might have (this is called its 'safety'). To do this, some people in the study will receive orforglipron, while others will receive a 'placebo', which looks identical but doesn't contain any active medicine. This allows doctors to compare the results and see if the new medicine is having a real effect.

This specific study is part of a bigger research effort investigating orforglipron. By participating, you would be helping medical science learn more about how to treat high blood pressure in people who also struggle with their weight, potentially leading to new treatment options in the future.

मुख्य निष्कर्ष

  • The study is testing a new medicine, orforglipron, for high blood pressure.
  • It's for adults who also have obesity or are overweight.
  • The goal is to check how well the medicine works and if it's safe.
  • Some participants will get the actual medicine, others a dummy pill.
  • भागीदारी में नियमित क्लिनिक दौरे और स्वास्थ्य जांच शामिल हैं।.
  • You can leave the study at any time if you change your mind.

कौन पात्र हो सकता है?

To be considered for this study, you must be 18 years old or older. The study is open to both men and women.

Since this study is part of a larger research programme, there are specific guidelines that decide who can and cannot take part. These guidelines are carefully considered to make sure the study is safe for everyone involved and that the results are clear.

If you are interested, a member of the research team will explain these guidelines in detail and check if you meet all the necessary requirements for screening. They will ask questions about your health and medical history.

क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?

यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.

  1. क्या आप 18 वर्ष या उससे अधिक आयु के हैं?
  2. Do you have high blood pressure?
  3. Are you currently overweight or living with obesity?
  4. क्या आप नियमित क्लिनिक अपॉइंटमेंट्स में शामिल हो सकते हैं?
अपने परिणाम देखने के लिए हर प्रश्न का उत्तर दें।.

भागीदारी में क्या शामिल है?

Taking part in this study would involve a series of visits to the clinic over a period of time. During these visits, you would have various health checks, such as measurements of your blood pressure, weight, and blood tests. You would be given either the study medicine (orforglipron) or a dummy pill (placebo) to take regularly, as instructed by the study team.

The specific number of visits and the total length of your participation would be explained fully by the study team during your initial conversations. There will also be follow-up appointments to monitor your health and how you are responding to the medication. All procedures, including medication doses and the duration of the study, will be carefully set out in the study plan.

संभावित जोखिम और लाभ

Potential benefits of taking part could include closer monitoring of your blood pressure and general health, and possibly experiencing an improvement in your blood pressure if you receive the active medicine. However, like all medicines, orforglipron may have side effects, and some people might not improve or could even feel worse. All possible risks will be fully explained before you agree to participate. Remember, joining a clinical trial is always your choice, and you are free to withdraw at any time without giving a reason, and it will not affect your usual medical care.

Locations (99)

  • Elite Clinical Studies, LLC
    सत्यापित पोस्टकोड
    फीनिक्स, संयुक्त राज्य अमेरिका
  • Valley Clinical Trials, Inc.
    सत्यापित पोस्टकोड
    कोविना, संयुक्त राज्य अमेरिका
  • Valley Clinical Trials, Inc.
    सत्यापित पोस्टकोड
    नॉर्थरिज, संयुक्त राज्य अमेरिका
  • Chase Medical Research, LLC
    सत्यापित पोस्टकोड
    Waterbury, United States
  • Excel Medical Clinical Trials
    सत्यापित पोस्टकोड
    बोका रैटन, संयुक्त राज्य अमेरिका
  • Care Access - Brandon
    सत्यापित पोस्टकोड
    ब्रैंडन, संयुक्त राज्य अमेरिका
  • Northeast Research Institute - Downtown Office
    सत्यापित पोस्टकोड
    जैक्सनविल, संयुक्त राज्य अमेरिका
  • Peace River Cardiovascular Center
    सत्यापित पोस्टकोड
    पोर्ट शार्लोट, संयुक्त राज्य अमेरिका
  • East-West Medical Research Institute
    सत्यापित पोस्टकोड
    Honolulu, United States
  • Sinai Hospital Of Baltimore
    सत्यापित पोस्टकोड
    बाल्टीमोर, संयुक्त राज्य अमेरिका
  • Ascension Saint Agnes Heart Care
    सत्यापित पोस्टकोड
    बाल्टीमोर, संयुक्त राज्य अमेरिका
  • Lucida Clinical Trials
    सत्यापित पोस्टकोड
    New Bedford, United States

सामान्य प्रश्न

उच्च रक्तचाप क्या है?

High blood pressure, or hypertension, means your blood is pushing too hard against the walls of your arteries. Over time, this can damage your blood vessels and lead to serious health problems like heart disease or stroke.

What is 'obesity or overweight' in this study?

This refers to having a body weight that is higher than what is considered healthy for your height. The study will use specific measurements, like Body Mass Index (BMI), to determine this.

'प्लेसबो' क्या है?

A placebo is a 'dummy' pill or treatment that looks exactly like the real medicine but contains no active drug. It helps researchers see if the real medicine is actually working or if improvements are due to other factors.

क्या मुझे पता चलेगा कि मुझे असली दवा मिल रही है या प्लेसीबो?

No, neither you nor the study team will know whether you are receiving the active medicine or the placebo. This is to ensure the study results are fair and unbiased. This is called 'blinding'.

क्या मैं अध्ययन में भाग लेना बंद कर सकता हूँ यदि मैं चाहूँ?

Yes, absolutely. Your participation is completely voluntary, and you can choose to leave the study at any time, for any reason, without it affecting your future medical care.

और अधिक जानने के लिए कैसे पता करें

किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.

चर्चा

समुदाय चर्चा

हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.